Carl N Kraus
CIK 1946475 · Chief Medical Officer · last filed 2025-10-17
Carl N Kraus is a Chief Medical Officer who has filed 9 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing shows the insider sold $141.9K of AQST on Oct 17, 2025. Across all open-market trades the lifetime net is −$141.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.18M
3
9
-$141.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AQST | Chief Medical Officer | 282,475 | $4.17 | $1.18M | -$141.9K | 6 | 2025-10-17 |
| Aceragen, Inc. (ACGN) Delisted | CHIEF MEDICAL OFFICER | — | $0.38 | — | $0 | 1 | 2023-02-02 |
| Aceragen, Inc. (IDRA) Delisted | Chief Medical Officer | — | $7.22 | — | $0 | 1 | 2022-09-30 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-17 | AQST | Sell (S) | −20,272 | -$141.9K | EDGAR |
| 2025-08-12 | AQST | Tax (F) | −10,819 | -$42.2K | EDGAR |
| 2025-03-11 | AQST | Mixed | +61,885 | -$21.5K | EDGAR |
| 2024-08-12 | AQST | Tax (F) | −10,819 | -$37.1K | EDGAR |
| 2024-03-11 | AQST | Grant (A) | +112,500 | $0 | EDGAR |
| 2023-08-09 | AQST | Grant (A) | +150,000 | $0 | EDGAR |
| 2023-02-02 | Aceragen, Inc. (ACGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | — | Exer (M) | — | $0 | |
| 2022-09-30 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |